HA
ISRG icon

Harfst & Associates’s Intuitive Surgical ISRG Stock Holding History

Harfst & Associates’s Portfolio ISRG Stock Details ISRG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
4,078
+468
+13% +$204K 0.25% 71
2026
Q1 		$1.66M Buy
3,610
+443
+14% +$224K 0.3% 64
2025
Q4 		$1.79M Buy
3,167
+56
+2% +$29.8K 0.32% 58
2025
Q3 		$1.39M Buy
3,111
+92
+3% +$44.1K 0.26% 76
2025
Q2 		$1.64M Buy
3,019
+1,663
+123% +$870K 0.34% 59
2025
Q1 		$672K Buy
+1,356
New +$750K 0.16% 78
2021
Q1 		– Sell
-2,370
Closed -$646K – 141
2020
Q4 		$646K Buy
2,370
+867
+58% +$215K 0.24% 75
2020
Q3 		$355K Buy
1,503
+48
+3% +$10.8K 0.15% 86
2020
Q2 		$276K Buy
1,455
+18
+1% +$3.23K 0.12% 92
2020
Q1 		$237K Buy
1,437
+18
+1% +$3.3K 0.12% 88
2019
Q4 		$279K Sell
1,419
-15
-1% -$2.81K 0.11% 85
2019
Q3 		$258K Buy
1,434
+96
+7% +$16.6K 0.11% 84
2019
Q2 		$233K Hold
1,338
– – 0.1% 87
2019
Q1 		$254K Buy
1,338
+48
+4% +$8.53K 0.11% 86
2018
Q4 		$205K Buy
1,290
+30
+2% +$5.08K 0.1% 86
2018
Q3 		$241K Buy
+1,260
New +$224K 0.1% 77

Other funds holding ISRG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Harfst & Associates's ISRG Position: Q2 2026 in Review

Harfst & Associates increased its Intuitive Surgical (ISRG) stake by 13% in Q2 2026, buying an estimated $204K and bringing the position to 4,078 shares worth $1.62M. The position accounts for 0.25% of the portfolio, ranked #71.

Harfst & Associates first reported a position in ISRG in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.79M in Q4 2025. 2,246 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Harfst & Associates held 4,078 shares of Intuitive Surgical worth $1.62M as of Q2 2026.
  • Harfst & Associates bought 468 Intuitive Surgical shares in Q2 2026, an estimated $204K.
  • Intuitive Surgical made up 0.25% of Harfst & Associates's portfolio in Q2 2026, its #71 holding.
  • Harfst & Associates first reported a position in Intuitive Surgical in Q3 2018 and has held it in 16 quarters since.
  • Harfst & Associates's Intuitive Surgical position peaked at $1.79M in Q4 2025.
  • 2,246 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Harfst & Associates's 13F filing for Q2 2026, filed 31 Jul 2026.